COLABORA El Meu Clínic . Este enlace se abre en una nueva pestaña.
Buscar
COLABORA El Meu Clínic . Este enlace se abre en una nueva pestaña.
Hilo de navegación
Cèlia Painous

Cèlia Painous

Grupo de investigación

//orcid.org/0000-0002-7027-3093 0000-0002-7027-3093

Sobre mí

Cèlia Painous graduated in Medicine by University of Barcelona in 2013. She completed her neurology residency training at the Hospital de la Sta. Creu i St. Pau (2014-2018). She also expanded her knowledge in clinical research through the Master’s Degree in Research Methodology in Health Sciences at the Universitat Autònoma de Barcelona (2016-2020). In 2018 she did 4-months fellowship in Movement disorders with Prof. Bhatia from Queen’s Square Hospital in London. In June 2018 she joined the Movement Disorders Unit of Hospital Clinic as PhD student. she was awarded a Río Hortega grant from the Carlos III Health Institute in 2019. Her PhD, directed by Dr. Compta, tries to identify clinical, biological and neuroimaging biomarkers in atypical parkinsonisms and specifically in progressive sup

Publicaciones destacadas

  • Progression of Motor and Non-Motor Symptoms in Multiple System Atrophy: A Prospective Study from the Catalan-MSA Registry

    Autores:
    Pérez-Soriano A, Giraldo DM, Ríos J, Muñoz E, Compta Y, Martí MJ; Catalán MSA Registry (CMSAR);
    Referencia: 2021.

  • Association of PSP phenotypes with survival: A brain-bank study

    Autores:
    Guasp M; Molina-Porcel L; Painous C; Caballol N; Camara A;
    (...)
    Grau O; Gelpí E; Respondek G; Höglinger GH; Compta Y.
    Referencia: Parkinsonism &Amp; Related Disorders 2021.

  • Video-tutorial for the Movement Disorder Society criteria for progressive supranuclear palsy

    Autores:
    8) Iankova V, Respondek G, Saranza G, Painous C, Cámara A, Compta Y, Aiba I, Balint B, Giagkou N, Josephs KA, Otsuki M, Golbe LI, Bhatia KP, Stamelou M, Lang AE, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group;
    Referencia: Parkinsonism & Related Disorders 2020.

  • Management of rare movement disorders in Europe: outcome of surveys of the European Reference Network for Rare Neurological Diseases.

    Autores:
    Painous C; van Os NJH; Delamarre A; Michailoviene I; Marti MJ;
    (...)
    Meissner WG; Utkus A; Reinhard C; Graessner H; Tijssen MA.
    Referencia: The European Journal Of Neurology 2020.

  • Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study

    Autores:
    1) Painous C; Martí MJ; Simonet C; Garrido A; Valldeoriola F;
    Muñoz E; Cámara A; Compta Y.
    Referencia: 2020.

  • Cognitive Impairment in Parkinson’s Disease: What We Know so Far

    Autores:
    Painous C; Marti MJ;
    Referencia: Research And Reviews In Parkinsonism 2020.

  • Is serotonin pathology a good biomarker in vivo for early Parkinson's disease?

    Autores:
    Painous C; Perissinotti A; Martí MJ;
    Referencia: Annals Of Translational Medicine 2019.

  • Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study

    Autores:
    9) Compta Y, Dias SP, Giraldo DM, Pérez-Soriano A, Muñoz E, Saura J, Fernández M, Bravo P, Cámara A, Pulido-Salgado M, Painous C, Ríos J, Martí MJ; CMSAR consortium;
    Referencia: Parkinsonism &Amp; Related Disorders 2019.

  • Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease

    Autores:
    Aldaz T; Nigro P; Sánchez-Gómez A; Painous C; Planellas L;
    (...)
    Cámara A; Compta Y; Valldeoriola F; Martí MJ; Muñoz E.
    Referencia: Journal Of Neurology 2019.

  • Head and voice tremor improving with immunotherapy in an anti-NF155 positive CIDP patient

    Autores:
    Painous C; López-Pérez MÁ; Illa I; Querol L;
    Referencia: 2018.

Proyectos destacados

  • Amplificación de autoagregación de alfa-sinucleína y 4R-tau en tejido cerebral y líquido cerebrospinal mediante RTQuIC como biomarcador diferencial de parkinsonismos degenerativos.

    Financiador: ISCIII
    Código: PI17/00096
    Duración: 01/01/2018